EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis






Journal of Clinical Endocrinology and Metabolism 81(10): 3566-3572

Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis

Chronic pancreatitis (CP) is associated with lowered plasma levels and a blunted nutrient-induced release of pancreatic polypeptide (PP). To investigate the possible role of PP on glucose metabolism, we studied male patients with documented CP (n = 5) and obesitymatched control subjects (NL) (n = 6). Hepatic glucose production (HGP) and overall glucose disposal rates were determined by (3-3H)glucose infusion during a hyperinsulinemic-euglycemic clamp during three separate admissions. Basal rates of HGP were higher in CP patients. In response to an infusion of insulin (60 pmol cntdot m-2 cntdot min-1), HGP fell 91 +- 5% in NL subjects but only 68 +- 8% in CP subjects (P lt 0.05). One month later, the clamp was repeated during the final 2 h of an 8-h infusion of bovine PP (2 pmol cntdot kg-1 cntdot min-1). HGP before the insulin infusion and its subsequent suppression (NL: 83 +- 5%; CP: 86 +- 15%) were nearly identical between groups. In follow-up studies 1 month after the PP infusion, HGP both basally and in response to insulin alone were similar to the first study. During oral glucose tolerance tests (OGTT) performed 18 h after the PP infusion, subjects with normal (n = 7) baseline OGTT responses showed no effect. All patients with diabetic (n = 3) or nondiagnostic (n = 1) OGTT responses, however, demonstrated lowered mean plasma glucose levels ( apprx - 2.3 mmol/L; range: -0.6 to -7.2 mmol/L). OGTTs repeated 1 month after the PP treatment showed a return to pretreatment responses. We conclude that chronic pancreatitis accompanied by PP deficiency is associated with partial hepatic resistance both in the basal state and in response to hyperinsulinemia. This impairment is reversed after iv PP administration. PP deficiency may therefore play a role in the development of pancreatogenic diabetes caused by pancreatic injury.

(PDF same-day service: $19.90)

Accession: 002914848

PMID: 8855802

DOI: 10.1210/jcem.81.10.8855802



Related references

Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide. American Journal of Surgery 151(1): 130-140, 1986

Reversal of abnormal glucose metabolism in chronic pancreatitis by pancreatic polypeptide pp administration in man. Biomedical Research (Tokyo) 9(SUPPL 1): 27, 1988

Reversal of abnormal glucose production in chronic pancreatitis by administration of gastric inhibitory polypeptide and pancreatic polypeptide. Surgical Forum (Chicago) 38: 149-151, 1987

Interactions of pancreatic polypeptide glucagon and insulin on glucose metabolism in chronic pancreatitis. Digestive Diseases & Sciences 29(8 SUPPL): 24S, 1984

Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man. Surgery 104(2): 119-129, 1988

Abnormal pancreatic polypeptide and somatostatin immunostaining in experimental chronic pancreatitis. Gastroenterology 108(4 SUPPL ): A390, 1995

Changes in glucose metabolism after Kausch-Whipple pancreatectomy in pancreatic cancer and chronic pancreatitis patients. Pancreas 36(1): 26-30, 2008

Endoscopic measurement of pancreatic juice secretory flow rates and pancreatic secretory pressures after secretin administration in human controls and in patients with acute relapsing pancreatitis, chronic pancreatitis, and pancreatic cancer. American Journal of Surgery 136(5): 569-574, 1978

Pancreatic Polypeptide Secretion in Patients with Chronic Pancreatitis and After Pancreatic Surgery. International Journal of Gastrointestinal Cancer 29(3): 173-180, 2003

Pancreatic polypeptide response in patients with chronic pancreatitis. Digestive Diseases and Sciences 24(11): 862-864, 1979